Bills would fund research of psilocybin mushrooms to treat PTSD, depression (access required)

Arizona lawmakers are giving a big thumbs up to the party drug known as Ecstasy and turning on to hallucinogenic magic mushrooms, too. But don’t take this wrong – they’re not pushing the drugs for the usual recreational uses. Instead, bills that would fund a $30 million research program to study psilocybin mushrooms in treating post-traumatic stress syndrome and depression, and another to legalize the drug formally called MDMA for the same uses are advancing amid strong emerging evidence that they may be highly effective new therapies.

Complete access to news articles on azcapitoltimes.com is available to Arizona Capitol Times’ subscribers who are logged in. Subscribers may login at the login tab below. Others may join our audience of successful Arizonans with a subscription today.

Enter your user name and password in the fields above to gain access to the subscriber content on this site.

Your subscription includes one set of login credentials for your exclusive use. Security features have been integrated on this site: If someone signs in with your credentials while you are logged in, the site will automatically close your ongoing login and you will lose access at that time.

To inquire about group subscriptions for your organization please email Shaun Witt for special pricing.

If you feel your login credentials are being used by a second party, contact customer service at 877-615-9536 for assistance in changing your password.

Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.

Forgot your password?